Cash Advance Texas Cash Advance Texas
Half of People With Hepatitis C Don’t Complete Needed Tests: CDC
Baxter Immunoglobulin Fails to Aid Alzheimer’s Patients
Tanning Beds Should Carry Skin Cancer Warnings, FDA Says
Pfizer Begins Selling Viagra Online to Battle Fake Drugs
FDA Warns Shorter Name of New Roche Cancer Drug May Cause Confusion
Unmeltable, Uncrushable: The Holy Grail in Painkillers
J&J Recalls All Bottles of Children’s Tylenol in South Korea
Posted in Industry Stories
Big Drugmakers Think Small with Nanomedicine Deals
FDA Approves Merck Combination Cholesterol Lowering Pill
FDA Panel Votes Against Aveo’s Kidney Cancer Drug
Drugs from Amgen, Others Assessed by FDA as Radiation Treatments
Ask Well: Long-Term Risk of Antidepressants
Posted in Industry Stories
FDA Chief Defends Budget, Says Agency is Taxpayer ‘Bargain’
Guilty Plea Expected In Fake-Drugs Case
U.S. Accuses Novartis of Providing Kickbacks
Bristol-Myers Oral Hepatitis C Regimen Looks Competitive: Study
Posted in Industry Stories
Doctors Order Fewer Lab Tests When They Know the Cost
Drug Makers Use Safety Rule to Block Generics
FDA Can Be More Aggressive With Pharmacies, Hamburg Says
High Court Justices Seek Compromise in Gene-Patent Case
FDA Seeks More Data on Sarepta Muscular Dystrophy Drug
FDA Declines to Approve New Allergan Migraine Drug
Lilly Reports Positive Results from Two Trials of Diabetes Drug
Posted in Industry Stories
Pfizer Cancer Drug Wins Special Status; Shares Jump
Bristol-Myers to Spend $250 million to Expand Biologics Facility
GSK Plans $1 million Prize to Jump-start “Electroceuticals”
Biotech Industry at Stake in Human Gene Patent Decision
Acadia Gets Expedited FDA Review Path for Lead Drug
Posted in From Medical Dynamics
Lundbeck Antidepressant gets Boost from Clinical Trial
Roche to Use Isis’s Technology to Develop Brain Disorder Drug
Pharma Company Resverlogix to Spin Off Unit
FDA Advisers say Bausch & Lomb Implantable Lens Safe, Effective
Orphan Drug Prices Under Siege in Austerity-Minded Europe
Posted in Industry Stories
Anemia Drug Had Early Side Effects
Multiple Sclerosis Balloon Therapy Fails in Study
Exclusive – Pfizer, Novartis, Abbott Weigh Bids for Brazil’s Ache – sources
New-look Sarepta Eyes Approval for Muscular Dystrophy Drug
AstraZeneca Suffers Fresh Drug Patent Setback in U.S.
Posted in Industry Stories
Drug Makers’ Rising Interest in Injectables Could Ease Shortages
J&J Recalls 1.9 Million Blood Sugar Meters After Death
Drugmaker ‘Pay for Delay’ Accords Questioned by Top Court
Phytopharm Gives Up After Parkinson’s Drug Failure
Lundbeck to Develop, Sell Alzheimer’s Drug with Otsuka
Posted in Industry Stories
FDA Tightens Rules on Defibrillators as Recalls Mount
Biogen’s Tecfidera MS Drug Wins EU Agency’s Backing
Analysis: J&J’s Answer to Botox May Escalate War on Wrinkles
Medical Device Maker Cytori Loses Approval Fight
FDA Advisers Vote for Approval of Abbott’s Implantable Heart Device
Posted in Industry Stories
U.S. Drug Costs Dropped in 2012, but Rises Loom
Incyte Falls After Patient Develops Infection
Alzheimer’s Kills More in U.S. as Advocates Seek Funding
Biogen Receives Patent Until 2028 for Multiple Sclerosis Drug Tecfidera
Top Court to Hear Arguments Over Generic Drugmaker Liability
Posted in Industry Stories
SUBSCRIBE